US2009148925A1PendingUtilityA1

Single chain class I major histocompatibility complexes

Assignee: TECHNION RES & DEV FOUNDATIONPriority: Mar 27, 2000Filed: Jun 18, 2008Published: Jun 11, 2009
Est. expiryMar 27, 2020(expired)· nominal 20-yr term from priority
Inventors:Yoram Reiter
C07K 14/70539
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A recombinant polypeptide and nucleic acid constructs capable of expressing the recombinant polypeptide are provided. The recombinant polypeptide comprises a chimeric polypeptide including an antigenic peptide being capable of binding a human MHC class I, a functional human β-2 microglobulin and a functional human MHC class I heavy chain.

Claims

exact text as granted — not AI-modified
1 - 11 . (canceled) 
     
     
         12 . A nucleic acid construct comprising a first nucleic acid sequence encoding an antigenic peptide capable of binding a mammalian MHC class I, and a second nucleic acid sequence encoding a mammalian beta-2 microglobulin translationally fused upstream of a functional mammalian MHC class I heavy chain. 
     
     
         13 . The nucleic acid construct of  claim 12 , wherein said first nucleic acid sequence and said second nucleic acid sequence are translationally fused. 
     
     
         14 . The nucleic acid construct of  claim 13 , wherein said first nucleic acid sequence is translationally fused upstream of said second nucleic acid sequence. 
     
     
         15 . A bacterial cell transformed with a nucleic acid construct which comprises a first nucleic acid sequence encoding an antigenic peptide capable of binding a mammalian MHC class I, and a second nucleic acid sequence encoding a mammalian beta-2 microglobulin translationally fused upstream of a functional mammalian MHC class I heavy chain. 
     
     
         16 . The bacterial cell of  claim 15 , wherein said first nucleic acid sequence and said second nucleic acid sequence are translationally fused. 
     
     
         17 . The bacterial cell of  claim 15 , wherein said first nucleic acid sequence is translationally fused upstream of said second nucleic acid sequence.

Join the waitlist — get patent alerts

Track US2009148925A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.